NRX Pharmaceuticals Inc (FRA:B1Q)
€ 4.86 0 (0%) Market Cap: 12.65 Mil Enterprise Value: 18.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 30/100

NRX Pharmaceuticals Inc at H.C. Wainwright Neuropsychiatry Virtual Conference Transcript

Jun 26, 2023 / 01:00PM GMT
Release Date Price: €4.38 (-3.10%)
Brooke Katsof
H.C. Wainwright & Co., LLC - Analyst

Good morning, everyone, and thank you for joining the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference on June 26, 2023. My name is Brooke Katsof and I'm an H.C. Wainwright analyst. While we are virtual this year, we're confident we are going to be able to provide value to you with over 20 companies presenting at this conference.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services, public and private companies across multiple sectors and regions. Please join us for corporate presentations and panels that will be available live and streaming on June 26. That said, have a productive and enjoyable day.

And I'd like to introduce our first presenter. I'd like to welcome Jonathan Javitt, who is the Chief Scientist at NRX Pharmaceuticals; and Stephen Willard who's the CEO at NRX Pharmaceuticals.

Stephen Willard
NRX Pharmaceuticals, Inc. - CEO & Director

Thank you for inviting us to present to you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot